Topic Highlight
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 7, 2011; 17(13): 1674-1684
Published online Apr 7, 2011. doi: 10.3748/wjg.v17.i13.1674
Table 1 Patterns and rates of recurrences after different approaches
Authors - yearTreatment5-year local recurrence (%)
Metastases as a first site of recurrence (%)Median time to LR
TotalIsolatedCombined
Pilipshen et al[32] (1968-1976)Pre-TME surgery25.513.312.3NA16 mo
Heald et al[34] (1978-1986)TME surgery3.72.61.1NA14 mo
Swedish Trial[39] (1987-1990)Pre-TME surgery/23.013.010.011NA
sRT+ pre-TME9.05.04.019
Mohiuddin et al[67] (1976-1989)LRT+ Pre-TME13.06.07.01725 mo
German Trial[25] (1995-2002)CRT+ TME/6.03.03.020NA
TME + CRT13.07.06.020
British Trial[44] (1998-2005)sRT +TME/4.72.02.719NA
TME+ selective CRT11.56.15.421
Dutch Trial[41] (1996-1999)TME surgery/11.36.64.717 19.318 mo
sRT+ TME5.82.33.530 mo
Guillem et al[4] (1988-2002)CRT+TME4.32.32.02223 mo
Yu et al[54] (1989-2001)CRT+TME8.36.32.0NANA
Kim et al[56] (2001-2005)CRT+TME8.03.74.31924 mo central 18 mo lateral
Kusters et al[58] (1993-2002)Unilateral EL/15.4 (only T3,T4 tumors)NANA
Bilateral EL8.3 (only T3-T4 tumors)
Moriya et al[57] (1982-1991)Nerve-sparing EL6.2 (14 for N+ tumors)1217 mo